DUBLIN, Ohio, Sept. 19 /PRNewswire-FirstCall/ -- Alliance Boots and
Cardinal Health today announced a sourcing and marketing agreement for the
sale of Almus generic prescription medicines.
Cardinal Health is a global provider of products and services that
improve the safety and productivity of health care. Alliance Boots is an
international, pharmacy-led health and beauty group.
The two companies have formed a marketing entity to serve as a platform
for the introduction of the Almus brand of generic medicines into the U.S.
market. Generic pharmaceuticals sourced through this agreement will over
time be labeled under the Almus brand and will be distributed by Cardinal
Health in the United States. The agreement will enable both companies to
gain additional, global experience in an increasingly competitive
marketplace for generic pharmaceuticals.
"This joint agreement brings us a step closer to making Almus a truly
international brand. We are very pleased to be working with Cardinal
Health, combining our strengths and competencies to deliver Almus to the
largest pharmaceutical medicines market in the world," said Ornella Barra,
wholesale and commercial affairs director, Alliance Boots.
"This agreement will enable us to explore new ways to deliver
additional value to our retail pharmacy and SOURCE(SM) customers," said
Mark Parrish, CEO of Healthcare Supply Chain Services for Cardinal Health.
About Alliance Boots
Alliance Boots is a leading, international pharmacy-led health and
beauty group and European market leader in its two core businesses, retail
pharmacy and pharmaceutical wholesale. Alliance Boots has a wholesale
network serving more than 120,000 pharmacies, hospitals and health centers
via around 380 depots (including associates), and operates Europe's leading
retail pharmacy business with around 3,100 retail outlets, of which
approximately 2,800 have a pharmacy. It has around 100,000 employees in
more than 15 countries with revenue of £14.6 billion for the year ended 31
March 2007.
About Cardinal Health
Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is an
$87 billion, global company serving the health-care industry with products
and services that help hospitals, physician offices and pharmacies reduce
costs, improve safety, productivity and profitability, and deliver better
care to patients. With a focus on making supply chains more efficient,
reducing hospital-acquired infections and breaking the cycle of harmful
medication errors, Cardinal Health develops market-leading technologies,
including Alaris(R) IV pumps, Pyxis(R) automated dispensing systems,
MedMined(R) data mining software and the CareFusion(TM) patient
identification system. The company also manufactures medical and surgical
products and is one of the largest distributors of pharmaceuticals and
medical supplies worldwide. Ranked No. 19 on the Fortune 500 and No. 1 in
its sector on Fortune's ranking of Most Admired firms, Cardinal Health
employs more than 40,000 people on five continents. More information about
the company may be found at http://www.cardinalhealth.com.
SOURCE Cardinal Health
 back to top
Related links:
http://www.cardinalhealth.com/
CONTACT:
Media, Tara Schumacher, +1-614-757-6250,
tara.schumacher@cardinal.com, or Investors, Bob Reflogal,
+1-614-757-3413, bob.reflogal@cardinal.com, both of Cardinal
Health
|
